CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Captopril

卡托普利 杂质对照品Captopril Impurities

EP34 个杂质条目34 impurity entries

本页汇总 卡托普利 的 34 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 34 impurity reference standards of Captopril with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 卡托普利(Captopril)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesNIR hyperspectral imaging to evaluate degradation in captopril commercial tablets
    European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V · 2016 · França Lde M et al.  ·  PMID 27163244  ·  DOI
  2. 杂质研究Impurity studiesDetermination of captopril and its degradation products by capillary electrophoresis
    Journal of pharmaceutical and biomedical analysis · 1999 · Hillaert S, Van den Bossche W  ·  PMID 10701914  ·  DOI
  3. 杂质研究Impurity studiesStability of captopril in invert sugar solution
    Journal of clinical pharmacy and therapeutics · 1998 · Sam WJ, Ho PC  ·  PMID 10048506  ·  DOI
  4. 分析方法Analytical MethodsDevelopment and validation of a simple and sensitive HPLC-UV method for the determination of captopril in human plasma using a new derivatizing reagent 2-naphthyl propiolate
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences · 2013 · Rastkari N et al.  ·  PMID 23831707  ·  DOI

合成路线参考Reported synthetic routes

以下为公开文献中报道的合成方法(题录信息)。标题多已点明关键反应,可据此查阅原文了解完整路线与工艺条件。Published synthetic approaches. Titles usually name the key transformation; consult the original articles for full routes.

  • 合成方法SynthesisAn improved synthesis of captopril
    Journal of pharmaceutical sciences · 1984 · Nam DH et al.  ·  PMID 6396401  ·  DOI

卡托普利 —— 原料药与杂质对照品Captopril — drug substance & impurities

共 35 个条目(含原料药本体)35 items incl. the drug substance
Captopril structure
EP原料药 APIAPI
卡托普利Captopril
Captopril
CAS No.62571-86-2
Chemical FormulaC9H15NO3S
Purity>95%询价On request
10mg25mg50mg100mg
Captopril Impurity 1(Captopril EP Impurity A) structure
EPA
卡托普利杂质1(卡托普利EP杂质A)Captopril Impurity 1(Captopril EP Impurity A)
Captopril Impurity 1(Captopril EP Impurity A)
CAS No.64806-05-9
Chemical FormulaC18H28N2O6S2
Purity>95%询价On request
10mg25mg50mg100mg
Captopril Impurity 2(Captopril EP Impurity B) structure
EPB
卡托普利杂质2(卡托普利EP杂质B)Captopril Impurity 2(Captopril EP Impurity B)
Captopril Impurity 2(Captopril EP Impurity B)
CAS No.80629-35-2
Chemical FormulaC9H14BrNO3
Purity>95%询价On request
10mg25mg50mg100mg
Captopril Impurity 3(Captopril EP Impurity C) structure
EPC
卡托普利杂质3(卡托普利EP杂质C)Captopril Impurity 3(Captopril EP Impurity C)
Captopril Impurity 3(Captopril EP Impurity C)
CAS No.26473-47-2
Chemical FormulaC4H8O2S
Purity>95%询价On request
10mg25mg50mg100mg
Captopril Impurity 4(Captopril EP Impurity D) structure
EPD
卡托普利杂质4(卡托普利EP杂质D)Captopril Impurity 4(Captopril EP Impurity D)
Captopril Impurity 4(Captopril EP Impurity D)
CAS No.56970-78-6
Chemical FormulaC4H7BrO2
Purity>95%询价On request
10mg25mg50mg100mg
Captopril Impurity 6(Captopril EP Impurity E) structure
EPE
卡托普利杂质6(卡托普利EP杂质E)Captopril Impurity 6(Captopril EP Impurity E)
Captopril Impurity 6(Captopril EP Impurity E)
CAS No.23500-15-4
Chemical FormulaC9H15NO3
Purity>95%询价On request
10mg25mg50mg100mg
Captopril Impurity 5(Captopril EP Impurity F) structure
EPF
卡托普利杂质5(卡托普利EP杂质F)Captopril Impurity 5(Captopril EP Impurity F)
Captopril Impurity 5(Captopril EP Impurity F)
CAS No.63250-36-2
Chemical FormulaC9H15NO3S
Purity>95%询价On request
10mg25mg50mg100mg
Captopril Impurity 7(Captopril EP Impurity G) structure
EPG
卡托普利杂质7(卡托普利EP杂质G)Captopril Impurity 7(Captopril EP Impurity G)
Captopril Impurity 7(Captopril EP Impurity G)
CAS No.33325-40-5
Chemical FormulaC6H10O3S
Purity>95%询价On request
10mg25mg50mg100mg
Captopril Impurity 8 (Captopril EP Impurity H) structure
EPH
卡托普利杂质8 (卡托普利EP杂质H)Captopril Impurity 8 (Captopril EP Impurity H)
Captopril Impurity 8 (Captopril EP Impurity H)
CAS No.205521-07-9
Chemical FormulaC15H23NO5S2
Purity>95%询价On request
10mg25mg50mg100mg
Captopril Impurity 10(Captopril EP Impurity J) structure
EPJ
卡托普利杂质10(卡托普利EP杂质J)Captopril Impurity 10(Captopril EP Impurity J)
Captopril Impurity 10(Captopril EP Impurity J)
CAS No.64838-55-7
Chemical FormulaC11H17NO4S
Purity>95%询价On request
10mg25mg50mg100mg
Captopril Impurity 13 (Captopril EP Impurity N) structure
EPN
卡托普利杂质13 (卡托普利EP杂质N)Captopril Impurity 13 (Captopril EP Impurity N)
Captopril Impurity 13 (Captopril EP Impurity N)
CAS No.65134-74-9
Chemical FormulaC8H14O4S2
Purity>95%询价On request
10mg25mg50mg100mg
Captopril Impurity J Hydrate Salt structure
J
卡托普利杂质Captopril Impurity J Hydrate Salt
Captopril Impurity J Hydrate Salt
CAS No.801293-45-8
Chemical FormulaC11H19NO5S
Purity>95%现货In stock
10mg25mg50mg100mg
Captopril Impurity N1 structure
N1
卡托普利杂质N1Captopril Impurity N1
Captopril Impurity N1
CAS No.80141-53-3
Chemical FormulaC9H14ClNO3
Purity>95%现货In stock
10mg25mg50mg100mg
Captopril Impurity 6 structure
6
卡托普利杂质6Captopril Impurity 6
Captopril Impurity 6
CAS No.26315-61-7
Chemical FormulaC12H20O3
Purity>95%现货In stock
10mg25mg50mg100mg
Captopril Impurity 15 structure
15
卡托普利杂质15Captopril Impurity 15
Captopril Impurity 15
CAS No.112243-88-6
Chemical FormulaC9H15NO3S
Purity>95%询价On request
10mg25mg50mg100mg
Captopril Impurity 16 structure
16
卡托普利杂质16Captopril Impurity 16
Captopril Impurity 16
CAS No.119238-52-7
Chemical FormulaC9H15NO3S
Purity>95%询价On request
10mg25mg50mg100mg
Captopril Impurity 17 structure
17
卡托普利杂质17Captopril Impurity 17
Captopril Impurity 17
CAS No.613256-52-3
Chemical FormulaC9H15NO4
Purity>95%询价On request
10mg25mg50mg100mg
Captopril Impurity 18 structure
18
卡托普利杂质18Captopril Impurity 18
Captopril Impurity 18
CAS No.74345-73-6
Chemical FormulaC6H9ClO2S
Purity>95%询价On request
10mg25mg50mg100mg
Captopril Impurity 20 structure
20
卡托普利杂质20Captopril Impurity 20
Captopril Impurity 20
CAS No.75479-46-8
Chemical FormulaC12H20N2O5S2
Purity>95%询价On request
10mg25mg50mg100mg
Captopril Impurity 23 structure
23
卡托普利杂质23Captopril Impurity 23
Captopril Impurity 23
CAS No.26473-48-3
Chemical FormulaC4H8O2S
Purity>95%询价On request
10mg25mg50mg100mg
Captopril Impurity 24 structure
24
卡托普利杂质24Captopril Impurity 24
Captopril Impurity 24
CAS No.185804-96-0
Chemical FormulaC15H22N2O5S
Purity>95%询价On request
10mg25mg50mg100mg
Captopril Impurity 25 structure
25
卡托普利杂质25Captopril Impurity 25
Captopril Impurity 25
CAS No.122130-63-6
Chemical FormulaC9H14N2O4S
Purity>95%询价On request
10mg25mg50mg100mg
Captopril Impurity 26 structure
26
卡托普利杂质26Captopril Impurity 26
Captopril Impurity 26
CAS No.75107-57-2
Chemical FormulaC16H19NO4S
Purity>95%询价On request
10mg25mg50mg100mg
Captopril Impurity 29 structure
29
卡托普利杂质29Captopril Impurity 29
Captopril Impurity 29
CAS No.51161-88-7
Chemical FormulaC9H13NO3
Purity>95%询价On request
10mg25mg50mg100mg
Captopril Impurity 33 structure
33
卡托普利杂质33Captopril Impurity 33
Captopril Impurity 33
CAS No.69570-39-4
Chemical FormulaC6H9ClO2S
Purity>95%询价On request
10mg25mg50mg100mg
Captopril Impurity 35 structure
35
卡托普利杂质35Captopril Impurity 35
Captopril Impurity 35
CAS No.623-51-8
Chemical FormulaC4H8O2S
Purity>95%询价On request
10mg25mg50mg100mg
Captopril Impurity 36 structure
36
卡托普利杂质36Captopril Impurity 36
Captopril Impurity 36
CAS No.83494-29-5
Chemical FormulaC5H8F2O2S
Purity>95%询价On request
10mg25mg50mg100mg
Captopril Impurity 37 structure
37
卡托普利杂质37Captopril Impurity 37
Captopril Impurity 37
CAS No.505-73-7
Chemical FormulaC4H6O4S2
Purity>95%询价On request
10mg25mg50mg100mg
Captopril Impurity 38 structure
38
卡托普利杂质38Captopril Impurity 38
Captopril Impurity 38
CAS No.10047-28-6
Chemical FormulaC6H12O2S
Purity>95%询价On request
10mg25mg50mg100mg
Captopril Impurity 39 structure
39
卡托普利杂质39Captopril Impurity 39
Captopril Impurity 39
CAS No.7659-86-1
Chemical FormulaC10H20O2S
Purity>95%询价On request
10mg25mg50mg100mg
Captopril Impurity 40 structure
40
卡托普利杂质40Captopril Impurity 40
Captopril Impurity 40
CAS No.57253-30-2
Chemical FormulaC5H9Br
Purity>95%询价On request
10mg25mg50mg100mg
Captopril Impurity 41 structure
41
卡托普利杂质41Captopril Impurity 41
Captopril Impurity 41
CAS No.38293-65-1
Chemical FormulaC8H14O4S
Purity>95%询价On request
10mg25mg50mg100mg
Captopril Impurity 42 structure
42
卡托普利杂质42Captopril Impurity 42
Captopril Impurity 42
CAS No.224626-08-8
Chemical FormulaC11H17NO4S
Purity>95%询价On request
10mg25mg50mg100mg
Captopril Impurity 43 structure
43
卡托普利杂质43Captopril Impurity 43
Captopril Impurity 43
CAS No.13095-73-3
Chemical FormulaC4H8O2S
Purity>95%询价On request
10mg25mg50mg100mg
Captopril Impurity 44 structure
44
卡托普利杂质44Captopril Impurity 44
Captopril Impurity 44
CAS No.646-01-5
Chemical FormulaC4H8O2S
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

卡托普利 —— 研究文献与合成路线Captopril — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 卡托普利 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Captopril. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Influence of tiopronin, captopril and levamisole therapeutics on the oxidative degradation of hyaluronan
    Valachová K, Baňasová M, Topoľská D, et al. · Carbohydrate polymers · 2015 · 被引 38cited 38
  2. Determination of captopril and its degradation products by capillary electrophoresis
    Hillaert S, Van den Bossche W · Journal of pharmaceutical and biomedical analysis · 1999 · 被引 24cited 24
  3. ADAMTS-1 contributes to the antifibrotic effect of captopril by accelerating the degradation of type I collagen in chronic viral myocarditis
    Guo C, Wang Y, Liang H, et al. · European journal of pharmacology · 2010 · 被引 17cited 17
  4. Effects of peptidase inhibitors on the [Met5]-enkephalin hydrolysis in ileal and striatal preparations of guinea-pig: almost complete protection of degradation by the combination of amastatin, captopril and thiorphan
    Hiranuma T, Oka T · Japanese journal of pharmacology · 1986 · 被引 18cited 18
  5. Circular Dichroism Spectroscopy: A Facile Approach for Quantitative Analysis of Captopril and Study of Its Degradation
    Rahman N, Khan S · ACS omega · 2019 · 被引 13cited 13
  6. NIR hyperspectral imaging to evaluate degradation in captopril commercial tablets
    França Lde M, Pimentel MF, Simões Sda S, et al. · European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V · 2016 · 被引 10cited 10

合成与制备工艺专利Synthesis & process patents

  1. Sustained-release preparation containing captopril and hydrochlorothiazide and preparation process thereof
    LU HONGSHU · 公开号 CN1994306CN1994306 · 2007
  2. Controlled release preparation of captopril and its preparation process
    LUO KUAIYAN GUO · 公开号 CN1546018CN1546018 · 2004
  3. MAGNETIC TARGETING AND SLOW-RELEASING CAPTOPRIL AND PREPARING METHOD THEREOF
    DUAN Xue, ZHANG Hui, SUN Hui · 公开号 WO2006050649WO2006050649 · 2006
  4. Supermolecular intercalation-structure slow-release captopril and its preparing method
    DUAN XUE, ZHANG HUI, XU XIANGYU · 公开号 CN1640395CN1640395 · 2005
  5. Preparation method of captopril compounding chitin polysaccharide slow release micro ball
    CHEN XIGUANG, SONG YIMIN, TANG XUEXI · 公开号 CN1596891CN1596891 · 2005

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

卡托普利 杂质谱研究要点Captopril — impurity profiling notes

下面这些是拿到 卡托普利 的 35 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 35 impurity entries for Captopril, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances